Zobrazeno 1 - 10 of 108 pro vyhledávání: '"V, Sopik"'
3
Meeting abstracts from the Annual Conference on Hereditary Cancers 2016
Autor: Asta Försti, E. N. Imyanitov, Tomasz Gromowski, Kari Hemminki, Jakub Lubiński, E. Marczyk, O. Aszurek, Oleg Oszurek, R. Sibilski, A. Loya, Wojciech Kluźniak, M. R. Akbari, M. Szwiec, M. Falco, H. Rudnicka, Jacek Gronwald, M. Siołek, B. Kozak-Klonowska, Tomasz Byrski, Ping Sun, N. Muhammad, N. Peruga, T. Mierzwa, R. Billings, Bohdan Górski, Tadeusz Dębniak, Wojciech Marciniak, Józef Kładny, A. Savanevich, S. G. Braye, V. Sopik, A. Mathe, Katarzyna Durda, Cezary Cybulski, R. Wiśniowski, S. Pietrzak, A. Wiechowska-Kozłowska, J. F. Forbes, E. Kilar, A. Morawski, Dagmara Dymerska, Andrzej Pławski, M. Wong-Brown, Grzegorz Kurzawski, M. A. Yusuf, Karolina Prajzendanc, Piotr Baszuk, Marcin Lener, Kelly A. Avery-Kiejda, Krystian Kaczmarek, M. Stawicka, K. Gugała, Z. Morawiec, M. Kuswik, S. Clark, A. Soluch, Piotr Waloszczyk, Rodney J. Scott, Katarzyna Paszkowska-Szczur, M. Posmyk, Steven A. Narod, M. Muszyńska, W. Locke, R. Posmyk, Katrzyna Jaworska-Bieniek, A Jakubowska, J. Jakubowicz, Grzegorz Sukiennicki, M. R. Lener, Dominika Wokołorczyk, K. Kąklewski, U. R. Rashid, C. Stirzaker, D. Surdyka, H. Naeemi, A. Kashyap, J. Tomiczek-Szwiec, Tomasz Huzarski, K. Tutlewska, Hanna Janiszewska, P. Domagała
Publikováno v: Hereditary Cancer in Clinical Practice. 15
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::93ff71bab304976181d29225827946b8
https://doi.org/10.1186/s13053-017-0081-x
Zobrazit plný text záznamu
5
The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania
Autor: J, Menkiszak, V, Sopik, A, Chudecka-Głaz, W, Domagała, E, Urasińska, H, Symonowicz, E, Majdanik, P, Waloszczyk, K, Sycz, M, Świniarska, T, Huzarski, C, Cybulski, T, Debniak, O, Oszurek, J, Lubinski, S A, Narod, J, Gronwald
Publikováno v: Clinical genetics. 91(2)
The aim of the study was to evaluate the impact of a regional population-based genetic testing program on the incidence of ovarian cancer in West Pomerania. Between 1999 and 2010, a total of 37,552 women ages 35 to 70 were tested for three BRCA1 foun
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::12bd5179941969f0d856aa694d004087
https://pubmed.ncbi.nlm.nih.gov/27623744
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Overdiagnosis in breast cancer chemoprevention trials
Autor: V. Sopik, Steven A. Narod
Publikováno v: Current Oncology
Volume 22
Issue 1
Pages 2191-10
Several randomized controlled trials have demonstrated that the preventive use of an antiestrogen agent such as tamoxifen1–4, raloxifene5–7, anastrozole8, or exemestane9 will reduce the incidence of estrogen receptor (er)–positive breast cancer
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf8b5f246bebfdfca3b0d7b8d2fbe19f
https://europepmc.org/articles/PMC4324352/
Zobrazit plný text záznamu
8
Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland
Autor: C, Cybulski, J, Lubiński, D, Wokołorczyk, W, Kuźniak, A, Kashyap, V, Sopik, T, Huzarski, J, Gronwald, T, Byrski, M, Szwiec, A, Jakubowska, B, Górski, T, Dębniak, S A, Narod, M R, Akbari
Publikováno v: Clinical genetics. 88(4)
A number of genes other than BRCA1 and BRCA2 have been associated with breast cancer predisposition, and extended genetic testing panels have been proposed. It is of interest to establish the full spectrum of deleterious mutations in women with famil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::942e9200edcb541652eedac51d040a8d
https://pubmed.ncbi.nlm.nih.gov/25330149
Zobrazit plný text záznamu
9
Genetic testing for RAD51C mutations: in the clinic and community
Autor: V, Sopik, M R, Akbari, S A, Narod
Publikováno v: Clinical genetics. 88(4)
Much of the observed familial clustering of breast and ovarian cancer cannot be explained by mutations in BRCA1 and BRCA2. Several other cancer susceptibility genes have been identified, but their value in routine clinical genetic testing is still un
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::96c5486698b88dc77b4352891b1d6532
https://pubmed.ncbi.nlm.nih.gov/25470109
Zobrazit plný text záznamu
10
BRCA1 and BRCA2 mutations and the risk for colorectal cancer
Autor: V, Sopik, C, Phelan, C, Cybulski, S A, Narod
Publikováno v: Clinical genetics. 87(5)
Women who carry a BRCA1 or BRCA2 mutation are at high risk of breast and ovarian cancer, and may be at moderately increased risk of other cancer types. This review examines studies to date that have evaluated the risk of BRCA1 and BRCA2 mutations for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a7bb5928d04dab17eef3f47adf40ae04
https://pubmed.ncbi.nlm.nih.gov/26566797
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje